This MedLibrary.org supplementary page on Gatifloxacin is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:
Related Sponsors
 |
|
|
Gatifloxacin
|
|
| Systematic (IUPAC) name | |
| 1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid | |
| Identifiers | |
| CAS number | |
| ATC code | J01 S01 |
| PubChem | |
| DrugBank | |
| Chemical data | |
| Formula | C19H22FN3O4 |
| Mol. mass | 375.394 g/mol |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Protein binding | 20% |
| Metabolism | ? |
| Half life | 7 to 14 hours |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status |
Rx only |
| Routes | Oral (discontinued), Intravenous (discontinued) ophthalmic |
Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, that like other members of that family, inhibits the bacterial enzymes DNA gyrase and topoisomerase IV. Bristol-Myers Squibb introduced Gatifloxacin in 1999 under the proprietary name Tequin for the treatment of respiratory tract infections, having licensed the medication from Kyorin Pharmaceutical Company of Japan. Allergan produces an eye-drop formulation called Zymar. Gatifloxacin is available as tablets and in various aqueous solutions for intravenous therapy.
Side-effects and removal from the market
A Canadian study published in the New England Journal of Medicine in March 2006 claims Tequin can have "life threatening" side effects including serious diabetes.1 An editorial by Dr. Jerry Gurwitz in the same issue called for the Food and Drug Administration (FDA) to consider giving Tequin a black box warning.2 This editorial followed distribution of a letter dated February 15 by Bristol-Myers Squibb to health care providers indicating action taken with the FDA to strengthen warnings for the medication.3 Subsequently it was reported on May 1, 2006 that Bristol-Myers Squibb would stop manufacture of Tequin, end sales of the drug after existing stockpiles were exhausted, and return all rights to Kyorin.4
Gatifloxacin is currently available only in the US and Canada as an ophthalmic solution.
In India it is sold in tablet as well as in eye drop formulations.
References
- ^ Park-Wyllie, Laura Y.; David N. Juurlink, Alexander Kopp, Baiju R. Shah, Therese A. Stukel, Carmine Stumpo, Linda Dresser, Donald E. Low, Muhammad M. Mamdani (March 2006). "Outpatient Gatifloxacin Therapy and Dysglycemia in Older Adults". The New England Journal of Medicine 354 (13): 1352–1361. doi:. PMID 16510739. http://content.nejm.org/cgi/content/abstract/354/13/1352. Retrieved on 1 May 2006. Note: publication date 30 March; available on-line 1 March
- ^ Gurwitz, Jerry H. (March 2006). "Serious Adverse Drug Effects — Seeing the Trees through the Forest". The New England Journal of Medicine 354 (13): 1413–1415. doi:. PMID 16510740. http://content.nejm.org/cgi/content/extract/354/13/1413. Retrieved on 1 May 2006.
- ^ Lewis-Hall, Freda (February 15, 2006). "Dear Healthcare Provider:" (PDF). Bristol-Myers Squibb. http://www.fda.gov/medwatch/safety/2006/tequin_DHCP.pdf. Retrieved on May 1.
- ^ Schmid, Randolph E. (May 1, 2006). "Drug Company Taking Tequin Off Market", Associated Press. Retrieved on 1 May 2006.
Wikipedia content modification information:
- This page was last modified on 10 December 2008, at 01:22.
Wikipedia Authorship and Review
Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.
Wikipedia Usage Guidelines
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Gatifloxacin".
The URL for this specific entry is:
All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.